Autoantibodies against 60-kDa heat shock protein in schizophrenia

European Archives of Psychiatry and Clinical Neuroscience

Volumn 248, Issue 6, 1998, Pages 282-288

  Schwarz, M J ^a   Riedel, M ^a   Gruber, R ^a   Muller N ^a   Ackenheil, M ^a  

^a UNIVERSITY OF MUNICH   (Germany)

Author keywords

60 kDa heat shock protein; IL 2R; subgroup; Immunology; Schizophrenia

Indexed keywords

AUTOANTIBODY; CLOZAPINE; HALOPERIDOL; HEAT SHOCK PROTEIN 60; INTERCELLULAR ADHESION MOLECULE 2; INTERLEUKIN 2; NEUROLEPTIC AGENT; OLANZAPINE; CHAPERONIN; INTERLEUKIN 2 RECEPTOR; NERVE CELL ADHESION MOLECULE;

ADULT; ANTIBODY TITER; ARTICLE; BLOOD BRAIN BARRIER; BLOOD LEVEL; CONTROLLED STUDY; FEMALE; HUMAN; IMMUNOPATHOLOGY; IMMUNOREACTIVITY; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SCHIZOPHRENIA; TREATMENT OUTCOME; ADOLESCENT; CEREBROSPINAL FLUID; CLINICAL TRIAL; IMMUNOLOGY; MIDDLE AGED; PSYCHOLOGY;

ADOLESCENT; ADULT; AUTOANTIBODIES; CHAPERONIN 60; FEMALE; HUMANS; MALE; MIDDLE AGED; NEURAL CELL ADHESION MOLECULES; RECEPTORS, INTERLEUKIN-2; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY;

EID: 0032217115     PISSN: 09401334     EISSN: None     Source Type: Journal    
DOI: 10.1007/s004060050051     Document Type: Article

References (34)

1. Arolt V, Weitzsch C, Wilke I, Nolte A, Pinnow M, Rothermundt M, Kirchner H (1997) Production of interferon-gamma in families with multiple occurrence of schizophrenia. Psychiatry Res 66: 145-152
2. Baron M, Stern M, Anavi R, Witz IP (1977) Tissue-binding factor in schizophrenic sera: a clinical and genetic study. Biol Psychiatry 12: 199-219
3. Beeson PB (1994) Age and sex associations of 40 autoimmune diseases. Am J Med 96: 457-462
4. Birnbaum G (1996) Stress proteins: their role in the normal central nervous system and in disease states, especially multiple sclerosis. In: Chofflon M, Steinman L (eds) Immunoneurology. Springer, Berlin Heidelberg New York
5. Birnbaum G, Kotilinek L, Schlievert P, Clark HB, Trotter J, Horvath E, Gao E, Cox M, Braun PE (1994) Immunologic cross-reactivity between a mycobacterial heat shock protein and myelin 2′, 3′ cyclic nucleotide 3′ phosphodiesterase. Neurology 44 [Suppl 2]: A146
6. Brenneman DE, Gozes I (1996) A femtomolar-acting neuroprotective peptide. J Clin Invest 97: 2299-2307
7. Brown IR, Rush SJ (1990) Expression of heat shock genes (HSP70) in the mammalian brain: distinguishing constitutively expressed and hyperthermia-inducible mRNA species. J Neurosci Res 25: 14
8. Dore-Duffy P, Newman W, Balabanov R, Lisak RP, Mainolfi E, Rothlein R, Peterson M (1995) Circulating soluble adhesion proteins in cerebrospinal fluid and serum of patients with multiple sclerosis: correlation with clinical activity. Ann Neurol 37: 55-62
9. Fernandez Botran R (1991) Soluble cytokine receptors: their role in immunoregulation. FASEB J 5: 2567-2574
10. Freedman MS, Buu NN, Ruijs TC, Williams K, Antel JP (1992) Differential expression of heat shock proteins by human glial cells. J Neuroimmunol 41: 231-238
11. Ganguli R, Brar JS, Solomon W, Chengappa KNR, Rabin BS (1992) Altered interleukin-2 production in schizophrenia: association between clinical state and autoantibody production. Psychiatry Res 44: 113-123
12. Hampel H, Schwarz MJ, Kötter HU, Schneider C, Müller N (1996) Cell adhesion molecules in the central nervous system. Drug News Perspect 9: 69-81
13. Harrison PJ, Procter AW, Exworthy T, Roberts GW, Najlerahim A, Barton AJ, Pearson RC (1993) Heat shock protein (HSP70) mRNA expression in human brain: effects of neurodegenerative disease and agonal state. Neuropathol Appl Neurobiol 19: 10
14. Higashi T, Takechi H, Uemura Y, Kikuchi H, Nagata K (1994) Differential induction of messenger-RNA species encoding several classes of stress proteins following focal cerebral ischemia in rats. Brain Res 650: 239
15. Kilidireas K, Latov N, Strauss DH, Aviva DG, Hashim GA, Gorman J M, Sadiq SA (1992) Antibodies to human 60 kD heat-shock protein in patients with schizophrenia. Lancet 340: 569-572
16. Lowenstein DH, Chan PH, Miles MF (1991) The stress protein response in cultured neurons: characterization and evidence for a protective role in excitotoxicity. Neuron 7: 1053-1060
17. Maes M, Bosmans E, Calabrese J, Smith R, Meltzer HY (1995) Interleukin-2 and interleukin-6 in schizophrenia and mania: effects of neuroleptics and mood stabilizers. J Psychiatr Res 29: 141-152
18. Mailhos C, Howard MK, Latchman DS (1993) Heat shock protects neuronal cells from programmed cell death by apoptosis. Neuroscience 55: 621-627
19. McAllister CG, Rapaport MH, Pickar D, Paul SM (1991) Autoimmunity and schizophrenia. In: Tamminga CA, Schulz SC (eds) Advances in neuropsychiatry and psychopharmacology, vol 1. Schizophrenia research. Raven Press, New York, pp 111-118
20. Müller N, Empl M, Putz A, Schwarz M, Ackenheil M (1997) Immunological effects of treatment in schizophrenia. In: Henneberg AE, Kaschka WP (eds) Immunological alterations in psychiatric diseases. Adv Biol Psychiatry 18: 78-84
21. Mutis T, Corneliss YE, Datema G, van den Elsen PJ, Ottenhoff THM, Vries RRP de (1994) Definition of a human suppressor T-cell epitope. Proc Natl Acad Sci USA 91: 9456
22. Panchapakesan J, Daglis M, Gatenby P (1992) Antibodies to 65 kD and 70 kD heat shock proteins in rheumatoid arthritis and systemic lupus erythematosus. Immunol Cell Biol 70: 295-300
23. Pandey RS, Gupta AK, Chaturvedi VC (1981) Autoimmune model of schizophrenia with special reference to anti-brain antibodies. Biol Psychiatry 16: 1123-1136
24. Pollmächer T, Hinze SD, Mullington J, Holsboer F (1995) Clozapine-induced increase in plasma levels of soluble interleukin-2 receptors (letter). Arch Gen Psychiatry 52: 877-878
25. Prabhakar S, Kurien E, Gupta RS, Zielinski S, Friedman MS (1994) Heat shock protein immunoreactivity in CSF: correlation with oligoclonal banding and demyelinating disease. Neurology 44: 1644
26. Rapaport MH, Lohr JB (1994a) Serum-soluble interleukin-2 receptors in neuroleptic-naive schizophrenic subjects and in medicated schizophrenic subjects with and without tardive dyskinesia. Acta Psychiatr Scand 90: 311-315
27. Rapaport MH, McAllister CG, Kim YS, Han JH, Pickar D, Nelson DL, Kirch DG, Paul SM (1994b) Increased serum soluble interleukin-2 receptors in Caucasian and Korean schizophrenic patients. Biol Psychiatry 35: 767-771
28. Reiber H, Felgenhauer K (1987) Protein transfer at the blood cerebrospinal fluid barrier and the quantitation of the humoral immune response within the central nervous system. Clin Chem Acta 163: 319-328
29. Rieckmann P, Nunke K, Burchhardt M, Albrecht M, Wiltfang J, Ulrich M, Felgenhauer K (1993) Soluble intercellular adhesion molecule-1 in cerebrospinal fluid: an indicator for the inflammatory impairment of the blood-cerebrospinal fluid barrier. J Neuroimmunol 47: 133-140
30. Sharief MK, Noori MA, Ciardi M, Cirelli A, Thompson EJ (1993) Increased levels of circulating ICAM-1 in serum and cerebrospinal fluid of patients with active multiple sclerosis. Correlation with TNF-alpha and blood-brain barrier damage. J Neuroimmunol 43: 15-21
31. Tibbling G, Link H, Ohmann S (1977) Principles of albumin and IgG analyses in neurological disorders. I. Establishment of reference values. Scand J Clin Lab Invest 37: 385-390
32. van de Stolpe A, van der Saag PT (1996) Intercellular adhesion molecule-1. J Mol Med 74: 13-33
33. Vass K, Welch WJ, Nowak TSJ (1988) Localization of 70-kDa stress protein induction in gerbil brain after ischemia. Acta Neuropathol 77: 128
34. Wilke I, Arolt V, Rothermund M, Weitzsch C, Hornberg M, Kirchner H (1996) Investigations of cytokine production in whole blood cultures of paranoid and residual schizophrenic patients. Eur Arch Psychiatry Clin Neurosci 246: 279-284